Insider Buying: Assura Plc (LON:AGR) Insider Purchases 306 Shares of Stock

Assura Plc (LON:AGRGet Free Report) insider Jayne Cottam purchased 306 shares of the business’s stock in a transaction on Tuesday, May 6th. The stock was purchased at an average price of GBX 49 ($0.65) per share, for a total transaction of £149.94 ($199.47).

Jayne Cottam also recently made the following trade(s):

  • On Monday, April 7th, Jayne Cottam bought 348 shares of Assura stock. The stock was purchased at an average price of GBX 43 ($0.57) per share, for a total transaction of £149.64 ($199.07).
  • On Wednesday, March 5th, Jayne Cottam purchased 363 shares of Assura stock. The shares were acquired at an average price of GBX 41 ($0.55) per share, with a total value of £148.83 ($197.99).

Assura Stock Down 0.1 %

Assura stock opened at GBX 48.72 ($0.65) on Friday. The firm has a market capitalization of £1.59 billion, a price-to-earnings ratio of -46.57, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The firm’s fifty day moving average price is GBX 46.94 and its two-hundred day moving average price is GBX 41.66. Assura Plc has a 1-year low of GBX 35.24 ($0.47) and a 1-year high of GBX 49.20 ($0.65). The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Further Reading

Insider Buying and Selling by Quarter for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.